Stock Detail
IMMUCELL CORPORATION
Diagnostic Substances
ICCC @ Yahoo Finance | ICCC Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $5.17 | $5.25 | $0.17 | 3.40% | 0.00 | $5.00 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $4.74 | $4.70 | 4,151 | 15.45M | 1,691 | 64.63 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 5.59 | 5.38 | 5.04 | 4.83 | 4.49 |
Stock Profile
ImmuCell Corporation engages in the research and development, manufacture, and sale of diagnostic tests and products for therapeutic and preventive use against certain infectious diseases in animals and humans. It offers animal health products, including First Defense, a scours preventive product, which is manufactured from cows' colostrum using the company's vaccine and milk protein purification technologies; Wipe Out Dairy Wipes, MASTiK, and California Mastitis Test, which aid in the detection and treatment of mastitis caused by bacterial infections; Rapid Johne's Test, a test that identifies cattle with symptomatic Johne's disease; and rpt, a milk progesterone test used by dairy producers to monitor the reproductive status of their cows. The company is also developing Crypto-Scan water diagnostic test for preventing cryptosporidium parvum infections in humans, as well as Mast Out, an intramammary infusion product, as an alternative to traditional antibiotics used in the treatment of mastitis in lactating dairy cows. The company serves veterinarians and producers in the dairy and beef industries in the United States. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.